Insider transactions

EDGAR

Anixa Biosciences Inc

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
21 transactions, 180,357 shares
Sum of shares × price per share: 521,771.6
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–31 of 31

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-30 Filed 2026-11-02KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0003.17
15,850

Derived: shares × price per share. Exact value 15850.00.

685,000Direct (D) No— Open filing 0001493152-26-049574 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-26Titterton Lewis H jr Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)8,0002.98
23,840

Derived: shares × price per share. Exact value 23840.00.

1,054,003Direct (D) No— Open filing 0001493152-26-048520 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-22KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)8,0002.72
21,760

Derived: shares × price per share. Exact value 21760.00.

680,000Direct (D) No— Open filing 0001493152-26-048144 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-09-30Catelani Michael Officer: President, COO, CFO
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,5002.84
15,620

Derived: shares × price per share. Exact value 15620.00.

50,000Direct (D) No— Open filing 0001493152-26-045053 Read from the filing’s XML Dispute this row
2026-09-24 Filed 2026-09-28KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)7,0002.78
19,460

Derived: shares × price per share. Exact value 19460.00.

672,000Direct (D) No— Open filing 0001493152-26-044458 Read from the filing’s XML Dispute this row
2026-09-24 Filed 2026-09-28Baskies Arnold M Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0002.76
13,800

Derived: shares × price per share. Exact value 13800.00.

140,572Direct (D) No— Open filing 0001493152-26-044457 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-25Titterton Lewis H jr Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)49,0362.69
131,906.84

Derived: shares × price per share. Exact value 131906.84.

1,046,003Direct (D) No— Open filing 0001493152-26-044250 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-14KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,0002.75
8,250

Derived: shares × price per share. Exact value 8250.00.

665,000Direct (D) No— Open filing 0001493152-26-042512 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-14Titterton Lewis H jr Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0002.73
27,300

Derived: shares × price per share. Exact value 27300.00.

996,967Direct (D) No— Open filing 0001493152-26-042502 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-11KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0002.76
13,800

Derived: shares × price per share. Exact value 13800.00.

662,000Direct (D) No— Open filing 0001493152-26-042302 Read from the filing’s XML Dispute this row
2026-07-31 Filed 2026-08-03KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0003.47
17,350

Derived: shares × price per share. Exact value 17350.00.

657,000Direct (D) No— Open filing 0001493152-26-035751 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Baskies Arnold M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)6,0003.13
18,780

Derived: shares × price per share. Exact value 18780.00.

141,000Direct (D) No— Open filing 0001493152-26-035122 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Baskies Arnold M Director
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)5,4283.46
18,780.88

Derived: shares × price per share. Exact value 18780.88.

135,572Direct (D) No
F1
  • F1 The reporting person exercised the stock options at this time due to their expiration on August 23, 2026. The disposal of shares reported herein represents shares withheld by Anixa Biosciences, Inc. (the registrant) to cover the exercise price of the stock options.
Open filing 0001493152-26-035122 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Baskies Arnold M Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (6,000) — exercise price 3.13
Disposed (D)6,0000—0Direct (D) No
F2
  • F2 Right-To-Buy, pursuant to a stock option grant dated August 23, 2013.
Open filing 0001493152-26-035122 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-28KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0003.44
17,200

Derived: shares × price per share. Exact value 17200.00.

652,000Direct (D) No— Open filing 0001493152-26-034952 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-27KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,1883.37
10,743.56

Derived: shares × price per share. Exact value 10743.56.

647,000Direct (D) No— Open filing 0001493152-26-034772 Read from the filing’s XML Dispute this row
2026-07-24 Filed 2026-07-27KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,0003.73
11,190

Derived: shares × price per share. Exact value 11190.00.

643,812Direct (D) No— Open filing 0001493152-26-034723 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-21KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0003.46
17,300

Derived: shares × price per share. Exact value 17300.00.

640,812Direct (D) No— Open filing 0001493152-26-034027 Read from the filing’s XML Dispute this row
2026-07-20 Filed 2026-07-20Titterton Lewis H jr Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,0003.47
41,640

Derived: shares × price per share. Exact value 41640.00.

986,967Direct (D) No— Open filing 0001493152-26-033949 Read from the filing’s XML Dispute this row
2026-07-15 Filed 2026-07-16Titterton Lewis H jr Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,7973.28
9,174.16

Derived: shares × price per share. Exact value 9174.16.

974,967Direct (D) No— Open filing 0001493152-26-033461 Read from the filing’s XML Dispute this row
2026-07-10 Filed 2026-07-13KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0003.04
15,200

Derived: shares × price per share. Exact value 15200.00.

635,812Direct (D) No— Open filing 0001493152-26-032961 Read from the filing’s XML Dispute this row
2026-06-16 Filed 2026-06-17Titterton Lewis H jr Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,8362.64
7,487.04

Derived: shares × price per share. Exact value 7487.04.

972,170Direct (D) No— Open filing 0001493152-26-029030 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-16KUMAR AMIT Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)21,0002.50
52,500

Derived: shares × price per share. Exact value 52500.00.

630,812Direct (D) No— Open filing 0001493152-26-028827 Read from the filing’s XML Dispute this row
2026-01-28 Filed 2026-01-29Baskies Arnold M Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)10,0003.04
30,400

Derived: shares × price per share. Exact value 30400.00.

135,000Direct (D) No— Open filing 0001493152-26-004148 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-06Titterton Lewis H jr Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option — underlying Common Stock (25,000) — exercise price 3.18
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
  • F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026.
Open filing 0001493152-26-000689 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-06Baskies Arnold M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option — underlying Common Stock (25,000) — exercise price 3.18
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
  • F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026.
Open filing 0001493152-26-000685 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-06KUMAR AMIT Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option — underlying Common Stock (350,000) — exercise price 3.18
Acquired (A)350,0000—350,000Direct (D) No
F1, F2
  • F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
  • F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026.
Open filing 0001493152-26-000688 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-06Catelani Michael Officer: President, COO CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option — underlying Common Stock (175,000) — exercise price 3.18
Acquired (A)175,0000—175,000Direct (D) No
F1, F2
  • F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
  • F2 The options vest and become exercisable in thirty-six (36) equal monthly installments beginning January 31, 2026.
Open filing 0001493152-26-000686 Read from the filing’s XML Dispute this row
2026-01-05 Filed 2026-01-06Gottschalk Emily Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option — underlying Common Stock (25,000) — exercise price 3.18
Acquired (A)25,0000—25,000Direct (D) No
F1, F2
  • F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
  • F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026.
Open filing 0001493152-26-000687 Read from the filing’s XML Dispute this row
2025-12-15 Filed 2025-12-16Titterton Lewis H jr Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)16,0002.92
46,720

Derived: shares × price per share. Exact value 46720.00.

969,334Direct (D) No— Open filing 0001493152-25-027904 Read from the filing’s XML Dispute this row
2025-12-15 Filed 2025-12-16Titterton Lewis H jr Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option — underlying Common Stock (16,000) — exercise price 2.92
Disposed (D)16,0000.00
0

Derived: shares × price per share. Exact value 0.00.

0Direct (D) No
F1
  • F1 Right-To-Buy, pursuant to a stock option grant dated February 18, 2016.
Open filing 0001493152-25-027904 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 80

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
VANGUARD CAPITAL MANAGEMENT LLC 1,329,852 SH3,896,466 dollarsUnchanged Prior quarter: 1,329,852Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager808,450 SH2,368,760 dollarsHigher by 480,118 Prior quarter: 328,332Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
Laird Norton Wetherby Trust Company, LLC 600,727 SH1,760,130 dollarsHigher by 22,000 Prior quarter: 578,727Open filing 0001172661-26-005286 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager586,815 SH1,719,368 dollarsHigher by 1,385 Prior quarter: 585,430Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
D.A. DAVIDSON CO. Partly reported under another manager494,949 SH1,450,201 dollarsLower by 44,323 Prior quarter: 539,272Open filing 0001080107-26-000007 Filed 2026-10-28 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager341,640 SH1,001,539 dollarsLower by 17,554 Prior quarter: 359,194Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager300,550 SH880,612 dollarsHigher by 241,177 Prior quarter: 59,373Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 210,213 SH615,924 dollarsHigher by 17,857 Prior quarter: 192,356Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager194,806 SH570,782 dollarsLower by 4,949 Prior quarter: 199,755Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
GSA CAPITAL PARTNERS LLP 181,019 SH530 dollarsHigher by 63,554 Prior quarter: 117,465Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager159,040 SH465,987 dollarsUnchanged Prior quarter: 159,040Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
LPL Financial LLC 114,835 SH336,467 dollarsHigher by 3,300 Prior quarter: 111,535Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
TWO SIGMA INVESTMENTS, LP 101,751 SH298,130 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager69,235 SH202,859 dollarsUnchanged Prior quarter: 69,235Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
CoreCap Advisors, LLC 62,020 SH181,719 dollarsHigher by 10,000 Prior quarter: 52,020Open filing 0001902501-26-000006 Filed 2026-10-08 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager54,926 SH160,933 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
CIBC Bancorp USA Inc. Partly reported under another manager53,200 SH155,876 dollarsHigher by 26,600 Prior quarter: 26,600Open filing 0001298088-26-000029 Filed 2026-11-13 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager47,442 SH139,007 dollarsUnchanged Prior quarter: 47,442Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager47,000 SH137,710 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Westside Investment Management, Inc. 43,000 SH125,990 dollarsUnchanged Prior quarter: 43,000Open filing 0001538383-26-000005 Filed 2026-11-02 Dispute this row
SIMPLEX TRADING, LLC Option: Call 41,200 SH120,716 dollarsHigher by 3,600 Prior quarter: 37,600Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
Kestra Advisory Services, LLC 40,500 SH118,665 dollarsHigher by 2,500 Prior quarter: 38,000Open filing 0001830819-26-000012 Filed 2026-11-19 Dispute this row
HighTower Advisors, LLC 39,380 SH115,383 dollarsLower by 1,770 Prior quarter: 41,150Open filing 0001085146-26-000933 Filed 2026-11-10 Dispute this row
Corient Private Wealth LP 37,400 SH109,582 dollarsUnchanged Prior quarter: 37,400Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row
First Affirmative Financial Network Partly reported under another manager36,000 SH105,480 dollarsNot in the prior quarter’s filings read Open filing 0001656282-26-000008 Filed 2026-10-21 Dispute this row
Gemmer Asset Management LLC 35,000 SH102,550 dollarsUnchanged Prior quarter: 35,000Open filing 0001420506-26-002328 Filed 2026-10-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager32,100 SH94,053 dollarsLower by 8,000 Prior quarter: 40,100Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Modern Wealth Management, LLC 32,000 SH93,760 dollarsUnchanged Prior quarter: 32,000Open filing 0002001900-26-000008 Filed 2026-11-16 Dispute this row
Vontobel Holding Ltd. Partly reported under another manager30,000 SH87,900 dollarsUnchanged Prior quarter: 30,000Open filing 0001588340-26-000004 Filed 2026-10-16 Dispute this row
MORGAN STANLEY Partly reported under another manager23,396 SH68,550 dollarsHigher by 17,253 Prior quarter: 6,143Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Jump Financial, LLC Partly reported under another manager22,803 SH66,813 dollarsNot in the prior quarter’s filings read Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 22,500 SH65,925 dollarsUnchanged Prior quarter: 22,500Open filing 0001109767-26-000013 Filed 2026-11-05 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager19,961 SH58,486 dollarsLower by 11,926 Prior quarter: 31,887Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
AXQ CAPITAL, LP 19,244 SH56,385 dollarsHigher by 4,611 Prior quarter: 14,633Open filing 0001420506-26-002583 Filed 2026-11-12 Dispute this row
KEYBANK NATIONAL ASSOCIATION/OH Partly reported under another manager15,810 SH46,323 dollarsUnchanged Prior quarter: 15,810Open filing 0001089877-26-000030 Filed 2026-11-04 Dispute this row
Robertson Stephens Wealth Management, LLC 15,649 SH45,852 dollarsUnchanged Prior quarter: 15,649Open filing 0001172661-26-004576 Filed 2026-10-16 Dispute this row
Dakota Wealth Management 15,000 SH43,950 dollarsUnchanged Prior quarter: 15,000Open filing 0001951757-26-001931 Filed 2026-11-12 Dispute this row
CONTINUUM WEALTH ADVISORS, LLC 13,752 SH40,293 dollarsNot in the prior quarter’s filings read Open filing 0001966482-26-000005 Filed 2026-10-20 Dispute this row
CANADA PENSION PLAN INVESTMENT BOARD 13,500 SH39,555 dollarsUnchanged Prior quarter: 13,500Open filing 0001104659-26-128255 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 12,785 SH37,460 dollarsLower by 13 Prior quarter: 12,798Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager12,300 SH36,039 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
WELLS FARGO COMPANY/MN Partly reported under another manager12,000 SH35,160 dollarsUnchanged Prior quarter: 12,000Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row
Simplicity Wealth,LLC 12,000 SH35,160 dollarsUnchanged Prior quarter: 12,000Open filing 0001062993-26-005517 Filed 2026-10-23 Dispute this row
BENJAMIN EDWARDS INC Partly reported under another manager11,200 SH32,816 dollarsUnchanged Prior quarter: 11,200Open filing 0001451623-26-000005 Filed 2026-11-12 Dispute this row
Integrated Wealth Concepts LLC 10,985 SH32,186 dollarsHigher by 100 Prior quarter: 10,885Open filing 0001737109-26-000008 Filed 2026-11-17 Dispute this row
Aptus Capital Advisors, LLC 10,985 SH32,186 dollarsHigher by 100 Prior quarter: 10,885Open filing 0001398344-26-020003 Filed 2026-11-13 Dispute this row
Vanguard Global Advisers, LLC 10,729 SH31,436 dollarsUnchanged Prior quarter: 10,729Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 10,500 SH30,765 dollarsUnchanged Prior quarter: 10,500Open filing 0001085146-26-000940 Filed 2026-11-13 Dispute this row
Private Advisor Group, LLC 10,421 SH30,534 dollarsHigher by 200 Prior quarter: 10,221Open filing 0001567755-26-000005 Filed 2026-11-10 Dispute this row
Equitable Holdings, Inc. Partly reported under another manager10,245 SH30,018 dollarsNot in the prior quarter’s filings read Open filing 0001333986-26-000063 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • World Investment Advisors 14,619 SH
  • Cetera Investment Advisers 13,750 SH
  • JANE STREET GROUP, LLC 13,300 SH
  • Sixth Street Partners Management Company, L.P. 12,798 SH
  • NewEdge Wealth, LLC 12,500 SH
  • Sanctuary Advisors, LLC 10,450 SH
  • NBT BANK, N.A. 2,000 SH
  • MERCER GLOBAL ADVISORS INC /ADV 1,000 SH
  • Avion Wealth 200 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Michael Catelani Common Stock7.02,468,103.0001/05/2026 Filed 2026-01-06SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-000691 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,598,888 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020224,461
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Anixa Biosciences Inc